Hi Vin,
I think you are being unduly hard on yourself. If 'smart' is involved, my substantial losses aren't evidence of much :) I'm still holding enough shares that I'd like to see this play out as other than a complete loss . . .
I think what has sucked many of us with scientific/medical backgrounds into the GTCB vortex, is the compelling biotech potential of GTCB. What is our downfall, is the huge divergence between that potential and and how it is being squandered by inept management -- with Cox leading the charge.
Tom Newberry's contempt for shareholders has been manifested in the past. I've never been impressed with his effect or veracity. Redlining his salary would seem a most reasonable step in preserving critical capital -- or at least give him a shovel and send him to the barn to shovel what he dispenses by phone/email now.
Take care,
MTB